Loading…
Lantheus Holdings, Inc. is projected to rise to $144.99 by 2027, a +37% move from its current price of $105.64. LNTH is currently trading above its 50-day average (a bullish sign). Technical indicators currently lean buy.
A data-driven summary — not financial advice. See the full breakdown below.
Live market data via Yahoo Finance · updated 7/12/2026
| Period | Min | Prediction | Max | Change |
|---|---|---|---|---|
| Jul 13 | $103.59 | $105.66 | $107.77 | +0.02% |
| Jul 14 | $102.76 | $105.68 | $108.68 | +0.04% |
| Jul 15 | $102.14 | $105.70 | $109.38 | +0.05% |
| Jul 16 | $101.61 | $105.72 | $109.98 | +0.07% |
| Jul 17 | $101.16 | $105.74 | $110.52 | +0.09% |
| Jul 18 | $100.75 | $105.75 | $111.01 | +0.11% |
| Jul 19 | $100.38 | $105.77 | $111.46 | +0.13% |
| Period | Min | Prediction | Max | Change |
|---|---|---|---|---|
| Week 1 | $100.38 | $105.77 | $111.46 | +0.13% |
| Week 2 | $98.35 | $105.91 | $114.04 | +0.25% |
| Week 3 | $96.85 | $106.04 | $116.10 | +0.38% |
| Week 4 | $95.62 | $106.17 | $117.89 | +0.51% |
| Week 5 | $94.57 | $106.31 | $119.51 | +0.63% |
| Week 6 | $93.63 | $106.44 | $121.00 | +0.76% |
| Week 7 | $92.79 | $106.58 | $122.41 | +0.89% |
Short-term targets derived from the forecast trend and recent volatility. Highly uncertain — not financial advice.
Lantheus Holdings, Inc. (LNTH) is a healthcare company that develops, manufactures, and commercializes diagnostic and therapeutic products worldwide. The portfolio includes DEFINITY, an injectable ultrasound enhancing agent used in echocardiography exams; TechneLite, a technetium generator for nuclear medicine procedures; Xenon-133, a radiopharmaceutical gas to assess pulmonary function; Neurolite, an injectable imaging agent to identify brain blood flow blocks after stroke; Cardiolite, an injectable Tc-99m-labeled imaging agent to assess blood flow to heart muscle; and PYLARIFY, an F 18-labelled PSMA-targeted PET imaging agent for imaging PSMA-positive lesions in prostate cancer.
The company also provides Automated Bone Scan Index, RELISTOR, aPROMISE, PYLARIFY AI, and flurpiridaz, among others, and has collaboration agreements with GE Healthcare; Curium Pharma; POINT; Regeneron; and Ratio Therapeutics LLC.
LNTH is listed with a current price of $103.86 and a market cap of $6.76B, ranking 1155. The current price, market position, and the breadth of diagnostic and therapeutic imaging products situate LNTH as a mid-cap healthcare stock with a diversified radiopharmaceutical and imaging portfolio. The long-range forecast shows a strong upside trajectory, with Avg prices rising across multiple years and substantial ROI growth, suggesting a meaningful appreciation path beyond the near term.
A major floor 31.3% below — a decisive break under it would weaken the trend.
The nearest floor, 8.8% below — buyers have tended to step in here.
The nearest ceiling, 5.0% above — a clean break opens room to run.
A major ceiling 12.6% above — clearing it would confirm fresh momentum.
Key LNTH support and resistance from recent price action — levels where the trend has historically paused or reversed. Percentages are the distance from the current price.
A snapshot of LNTH market posture derived from its technical indicators and recent volatility. Higher trend and alignment lean bullish; higher risk means larger swings.
Technical Analysis
Indicators computed on daily closing prices.
| Period | SMA | Action | EMA | Action |
|---|---|---|---|---|
| MA 5 | $104.92 | Buy | $105.96 | Sell |
| MA 10 | $107.38 | Sell | $106.25 | Sell |
| MA 20 | $106.27 | Sell | $105.27 | Buy |
| MA 50 | $99.47 | Buy | $99.46 | Buy |
| MA 100 | $88.91 | Buy | $91.11 | Buy |
| MA 200 | $74.67 | Buy | $83.18 | Buy |
| Name | Value | Action |
|---|---|---|
| RSI (14) | 53.62 | Neutral |
| Stoch RSI (14) | 21.87 | Neutral |
| CCI (20) | -20.08 | Neutral |
| Williams %R (14) | -65.27 | Info |
| MACD (12,26,9) | -0.76 | Sell |
| ROC (12) | -0.37 | Sell |
| Bollinger %B (20,2) | 0.44 | Neutral |
| Stochastic %K (14) | 34.73 | Neutral |
| TRIX (15) | 0.39 | Buy |
| Awesome (5,34) | 1.43 | Buy |
| Ultimate (7,14,28) | 41.93 | Neutral |
| Momentum (10) | -3.37 | Sell |
| Aroon Osc (25) | 56.00 | Buy |
| Hull MA (9) | 104.65 | Buy |
| ADX (14) | 24.46 | Buy |
| ATR (14) | 1.69 | Info |
The 30-day technical picture is bullish, with RSI14 at 60 indicating momentum leaning slightly bullish. The stock trades above both the SMA50 of $92.69 and the SMA200 of $70.86, supporting a constructive near-term trend. The stock’s 30-day range is $91.89 to $117.38, with a support level at $91.00 and a resistance at $105.03.
| Year | Min | Avg | Max | ROI | Sentiment |
|---|---|---|---|---|---|
| $64.25 | $105.64 | $140.76 | 0% | Neutral | |
| $118.38 | $144.99 | $185.92 | +37% | Bullish | |
| $147.04 | $183.66 | $242.18 | +74% | Bullish | |
| $178.74 | $226.89 | $305.83 | +115% | Bullish | |
| $207.98 | $267.77 | $367.72 | +153% | Bullish | |
| $227.64 | $296.87 | $414.39 | +181% | Bullish | |
| $249.53 | $329.30 | $466.47 | +212% | Bullish | |
| $270.14 | $360.48 | $517.53 | +241% | Bullish | |
| $315.96 | $426.06 | $619.28 | +303% | Bullish | |
| $382.66 | $521.18 | $766.30 | +393% | Bullish | |
| $560.27 | $797.92 | $1,231.68 | +655% | Bullish | |
| $1,257.26 | $1,929.01 | $3,199.89 | +17.3x | Bullish |
Current year — the forecast is anchored to the live price, so ROI shows 0%.
| Month | Min | Avg | Max | Change |
|---|---|---|---|---|
| July 2026 | $64.25 | $105.64 | $127.39 | +0.00% |
| August 2026 | $92.51 | $108.39 | $129.80 | +2.60% |
| September 2026 | $91.20 | $107.39 | $129.66 | -0.92% |
| October 2026 | $93.23 | $110.25 | $134.04 | +2.67% |
| November 2026 | $96.33 | $114.33 | $139.81 | +3.70% |
| December 2026 | $96.14 | $114.50 | $140.76 | +0.15% |
Click any year to see its month-by-month LNTH forecast. Min / Avg / Max are a bear / base / bull scenario; ROI is the projected move from the current price. Change is the month-over-month move in the average. Estimates, not guarantees.
In 2026, LNTH is projected to trade between $64.25 and $140.76, averaging $105.64 — a potential gain of 0% from today's $105.64. A consolidation phase looks the most probable path here.
Lantheus Holdings, Inc.'s 2027 outlook centres on $144.99, within a $118.38 to $185.92 range. That is up +37% on the projected 2026 average. That marks a +37% change versus current levels. Momentum favours further upside here.
By 2028, LNTH could reach as high as $242.18, with a base case around $183.66 and support toward $147.04 — roughly +74% from $105.64. Buyers look set to stay in control over this stretch.
Expect LNTH to range from $178.74 to $305.83 through 2029. The $226.89 average target implies a +115% move from current prices. That is up +24% on the projected 2028 average. Momentum favours further upside here.
The LNTH price prediction for 2030 points to an average of $267.77 (low $207.98, high $367.72) — a potential gain of +153% on today's $105.64. Buyers look set to stay in control over this stretch.
In 2031, LNTH is projected to trade between $227.64 and $414.39, averaging $296.87 — a potential gain of +181% from today's $105.64. That is up +11% on the projected 2030 average. Momentum favours further upside here.
Lantheus Holdings, Inc.'s 2032 outlook centres on $329.30, within a $249.53 to $466.47 range. That is up +11% on the projected 2031 average. That marks a +212% change versus current levels. Buyers look set to stay in control over this stretch.
By 2033, LNTH could reach as high as $517.53, with a base case around $360.48 and support toward $270.14 — roughly +241% from $105.64. Momentum favours further upside here.
Expect LNTH to range from $315.96 to $619.28 through 2034. The $426.06 average target implies a +303% move from current prices. That is up +18% on the projected 2033 average. Buyers look set to stay in control over this stretch.
The LNTH price prediction for 2035 points to an average of $521.18 (low $382.66, high $766.30) — a potential gain of +393% on today's $105.64. Momentum favours further upside here.
In 2040, LNTH is projected to trade between $560.27 and $1,231.68, averaging $797.92 — a potential gain of +655% from today's $105.64. That is up +53% on the projected 2035 average. Buyers look set to stay in control over this stretch.
Lantheus Holdings, Inc.'s 2050 outlook centres on $1,929.01, within a $1,257.26 to $3,199.89 range. That is up +142% on the projected 2040 average. That marks a +17.3x change versus current levels. Momentum favours further upside here.
Investing $1,000 in LNTH today (≈ 9.466111 LNTH) could be worth
$18,260.21
+$17,260.21 (+1726%) by 2050 · US Dollar
Based on the average projected LNTH price of $1,929.01 in 2050.
Based on the base (average) forecast scenario. FX rates are indicative. Estimates only — not financial advice.
See what a past investment in LNTHwould be worth at today's price.
$1,000 invested in LNTH on Jul 10, 2025 (≈ 11.928903 LNTH) would be worth
$1,260.17
+$260.17 (+26.0%) today · 1.26× · US Dollar
Based on a LNTH entry price of $83.83 vs. today's $105.64.
| Invested | Entry price | Value today | Return |
|---|---|---|---|
| 1 week ago | $109.89 | $961.32 | -3.9% |
| 1 month ago | $100.24 | $1,053.87 | +5.4% |
| 3 months ago | $80.59 | $1,310.83 | +31.1% |
| 6 months ago | $67.48 | $1,565.5 | +56.6% |
| 1 year ago | $83.83 | $1,260.17 | +26.0% |
| All time (5.0y) ago | $26.58 | $3,974.42 | +297.4% |
Past performance from historical market data — it does not predict future results. FX rates are indicative. Not financial advice.
Enter a price to see how it sits against our LNTH forecast.
Our base-case forecast reaches $210.00 around 2029.
Implied market cap at $210.00: $13.67B
The multi-year forecast portrays a strong acceleration in value, beginning with a 2026 avg of $103.86 (min $64.25, max $139.48; ROI 0; sentiment NEUTRAL) and progressing to a 2027 avg of $150.63 (ROI 45; sentiment BULLISH), 2028 avg $191.68 (ROI 84.6), and 2029 avg $235.17 (ROI 126.4). By 2030, the avg climbs to $286.86 (min $223.92, max $391.37; ROI 176.2; sentiment BULLISH), and by 2031 it reaches $312.99 (ROI 201.4), then $347.65 (ROI 234.7) in 2032, $401.17 (ROI 286.3) in 2033, $468.22 (ROI 350.8) in 2034, and $571.50 (ROI 450.3) in 2035, all with a BULLISH sentiment. The forecast continues to 2040 with Avg $890.05 (min $631.81, max $1,358.26; ROI 757; sentiment BULLISH) and by 2050 Avg $2,210.88 (min $1,463.43, max $3,616.12; ROI 2028.7; sentiment BULLISH).
These figures imply substantial upside over the long term, but they are estimates and depend on market conditions.
Tap a question to reveal the answer.
Avg $286.86; min $223.92; max $391.37; ROI 176.2%; sentiment BULLISH.
The long-term forecast shows a bullish trajectory, with Avg rising to $286.86 by 2030 and to $2,210.88 by 2050, and ROI climbing to 176.2% by 2030 and 2028.7% by 2050. These are estimates and not guarantees.
Yes. The 2040 Avg is $890.05 (below $1,000) and the 2050 Avg is $2,210.88 (above $1,000), indicating the price path surpasses $1,000 on the forecast horizon.
Current price is $103.86. The 30-day range is $91.89-$117.38, with support at $91.00 and resistance at $105.03. RSI14 is 60, and the SMA50 is $92.69 while the SMA200 is $70.86, indicating a bullish near-term tilt.
Market cap $6.76B; rank 1155.
Lantheus Holdings, Inc. Community Discussion
0Share your Lantheus Holdings, Inc. price prediction and read what the community thinks. Be respectful — comments are public and not financial advice.
Be the first to share your prediction…
What's your take? Add a comment above to start the conversation.